LT2125850T - Makrocikliniai polimorfai, kompozicijos, apimančios tokius polimorfus, jų gamybos ir panaudojimo būdai - Google Patents

Makrocikliniai polimorfai, kompozicijos, apimančios tokius polimorfus, jų gamybos ir panaudojimo būdai

Info

Publication number
LT2125850T
LT2125850T LTEP08713185.0T LT08713185T LT2125850T LT 2125850 T LT2125850 T LT 2125850T LT 08713185 T LT08713185 T LT 08713185T LT 2125850 T LT2125850 T LT 2125850T
Authority
LT
Lithuania
Prior art keywords
polymorphs
compositions
manufacture
methods
macrocyclic
Prior art date
Application number
LTEP08713185.0T
Other languages
English (en)
Lithuanian (lt)
Inventor
Yu-Hung Chiu
Tessie CHE
Alex Romero
Yoshi Ichikawa
Youe-Kong Shue
Original Assignee
Merck Sharp & Dohme Corp.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38661942&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=LT2125850(T) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Merck Sharp & Dohme Corp. filed Critical Merck Sharp & Dohme Corp.
Publication of LT2125850T publication Critical patent/LT2125850T/lt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
    • C07D407/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
LTEP08713185.0T 2007-01-22 2008-01-22 Makrocikliniai polimorfai, kompozicijos, apimančios tokius polimorfus, jų gamybos ir panaudojimo būdai LT2125850T (lt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US88195007P 2007-01-22 2007-01-22
US11/831,886 US7378508B2 (en) 2007-01-22 2007-07-31 Polymorphic crystalline forms of tiacumicin B
PCT/US2008/000735 WO2008091554A1 (en) 2007-01-22 2008-01-22 Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof

Publications (1)

Publication Number Publication Date
LT2125850T true LT2125850T (lt) 2018-08-10

Family

ID=38661942

Family Applications (1)

Application Number Title Priority Date Filing Date
LTEP08713185.0T LT2125850T (lt) 2007-01-22 2008-01-22 Makrocikliniai polimorfai, kompozicijos, apimančios tokius polimorfus, jų gamybos ir panaudojimo būdai

Country Status (23)

Country Link
US (5) US7378508B2 (OSRAM)
EP (3) EP2468761A1 (OSRAM)
JP (2) JP5468388B2 (OSRAM)
KR (2) KR20150006082A (OSRAM)
CN (2) CN102746353A (OSRAM)
BR (1) BRPI0806878A2 (OSRAM)
CA (2) CA2880860A1 (OSRAM)
CY (1) CY1120358T1 (OSRAM)
DK (1) DK2125850T3 (OSRAM)
ES (2) ES2821384T3 (OSRAM)
HR (1) HRP20180912T1 (OSRAM)
HU (2) HUE052444T2 (OSRAM)
IL (2) IL199984A0 (OSRAM)
LT (1) LT2125850T (OSRAM)
MX (2) MX2009007730A (OSRAM)
NZ (2) NZ601347A (OSRAM)
PL (2) PL2125850T3 (OSRAM)
PT (2) PT3412678T (OSRAM)
RU (1) RU2478643C2 (OSRAM)
SI (1) SI2125850T1 (OSRAM)
TR (1) TR201810589T4 (OSRAM)
TW (2) TWI425942B (OSRAM)
WO (1) WO2008091554A1 (OSRAM)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5113978B2 (ja) * 2003-11-21 2013-01-09 味の素株式会社 グルタミン酸誘導体の有機アミン塩及びその利用
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
PL2070530T3 (pl) * 2004-05-14 2016-06-30 Merck Sharp & Dohme Leczenie chorób związanych ze stosowaniem antybiotyków
US7935377B2 (en) * 2004-06-04 2011-05-03 Ajinomoto Co., Inc. Crystals of free (2R, 4R)-monatin and use thereof
US7378508B2 (en) * 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
US8247423B2 (en) * 2007-07-12 2012-08-21 Tragara Pharmaceuticals, Inc. Methods and compositions for the treatment of cancer, tumors, and tumor-related disorders
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法
EA027622B1 (ru) * 2010-02-05 2017-08-31 ОБЩЕСТВО С ОГРАНИЧЕННОЙ ОТВЕТСТВЕННОСТЬЮ "НоваМедика" Твердофазные формы макроциклических ингибиторов киназы
PE20130308A1 (es) * 2010-05-18 2013-04-06 Optimer Pharmaceuticals Inc Metodos para tratar infecciones bacterianas recurrentes
PE20140887A1 (es) * 2011-02-04 2014-08-14 Optimer Pharmaceuticals Inc Tratamiento de infecciones bacterianas
WO2013138748A1 (en) * 2012-03-16 2013-09-19 Optimer Pharmaceuticals, Inc. Prevention of clostridium difficile infection in high risk patients
US8722863B2 (en) 2012-05-10 2014-05-13 Teva Pharmaceutical Works Ltd. Solid state forms of fidaxomycin and processes for preparation thereof
EA201492059A1 (ru) * 2012-05-10 2015-02-27 Тева Фармасьютикал Уоркс Лтд. Твердые формы фидаксомицина и способы их получения
JO3464B1 (ar) 2013-01-15 2020-07-05 Astellas Pharma Europe Ltd التركيبات الخاصة بمركبات التياكوميسين
BR112015021501A2 (pt) 2013-03-08 2017-07-18 Cipla Ltd composição farmacêutica, composição farmacêutica espumável, processo para fabricação de uma composição farmacêutica para administração retal, lata de aerossol para uma composição farmacêutica, uso de uma composição farmacêutica e método para tratar ou manter a remissão de infecções causadas por clostridium difficile
CN103275152B (zh) * 2013-05-29 2015-11-18 华北制药集团新药研究开发有限责任公司 一种高纯度非达霉素的制备方法
CN103275153B (zh) * 2013-06-27 2016-03-23 华北制药集团新药研究开发有限责任公司 一种非达霉素晶体的制备方法
CN104560766B (zh) * 2013-10-16 2017-07-28 浙江海正药业股份有限公司 一种游动放线菌菌株及其应用
US20150141356A1 (en) * 2013-11-15 2015-05-21 Optimer Pharmaceuticals, Inc. Treatment of Clostridium Difficile Infection in High Risk Patients
EP3110826A1 (en) 2014-02-25 2017-01-04 OLON S.p.A. Process for preparing novel forms of tiacumicin b
WO2015127955A1 (en) 2014-02-25 2015-09-03 Olon S.P.A. A new polymorph of tiacumicin b and process for preparation thereof
PL3119793T3 (pl) * 2014-03-18 2018-07-31 Xellia Pharmaceuticals Aps Nowe polimorfy i nowe stany stałe tiakumycyny b
HRP20181756T1 (hr) 2014-05-09 2018-12-28 Astellas Pharma Europe Ltd. Režim liječenja sa spojem tiakumicina
US20150329582A1 (en) * 2014-05-13 2015-11-19 Jef DeBrabander Small molecule compounds selective against gram-negative bacterial infections
CN104098637B (zh) 2014-07-09 2017-01-04 浙江海正药业股份有限公司 一种纯化非达霉素的方法
MA41689A (fr) * 2014-10-15 2017-08-22 Bioxcel Corp Prévention ou traitement de troubles du sommeil au moyen d'une formulation de dexmédétomidine
US10548912B2 (en) 2015-07-03 2020-02-04 Astellas Pharma Europe Ltd. Dosage regimen for a tiacumicin compound
CN112190589A (zh) * 2020-11-17 2021-01-08 首都医科大学附属北京胸科医院 非达霉素在制备抑制鸟分枝杆菌活性的产品中的应用

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1458512A (en) * 1973-11-22 1976-12-15 Lepetit Spa Antibiotic substance
US4321362A (en) * 1980-06-12 1982-03-23 Eli Lilly And Company De(mycinosyloxy)tylosin and process for its production
US4918174A (en) 1986-09-26 1990-04-17 Abbott Laboratories Tiacumicin compounds
US5698155A (en) 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5583115A (en) 1995-05-09 1996-12-10 Abbott Laboratories Dialkyltiacumicin compounds
US5767096A (en) 1996-07-12 1998-06-16 Abbott Laboratories Bromotiacumicin compounds
JP2000072760A (ja) 1998-06-19 2000-03-07 Ajinomoto Co Inc 新規シストチアゾール類縁体
JP2000053514A (ja) 1998-08-06 2000-02-22 Aquas Corp レジオネラ属細菌が生産する殺菌性物質、これを用いた殺菌剤、水処理剤、スライム抑制剤、及びこれらの製造方法
JP2000239266A (ja) 1999-02-17 2000-09-05 Ajinomoto Co Inc 新規ポリエン系抗生物質
CA2404938C (en) 2000-04-28 2011-11-01 Kosan Biosciences, Inc. Production of polyketides
WO2002032427A1 (en) 2000-10-20 2002-04-25 Galephar M/F Stable oral formulation containing benzimidazole derivative
US20070105791A1 (en) 2002-07-29 2007-05-10 Optimer Pharmaceuticals, Inc. Method of treating clostridium difficile-associated diarrhea
EP2860241A1 (en) * 2002-07-29 2015-04-15 Optimer Pharmaceuticals, Inc. Tiacumicin production
PL2070530T3 (pl) * 2004-05-14 2016-06-30 Merck Sharp & Dohme Leczenie chorób związanych ze stosowaniem antybiotyków
US7906489B2 (en) 2004-05-14 2011-03-15 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
CA2596387C (en) * 2005-01-31 2012-11-20 Optimer Pharmaceuticals, Inc. 18-membered macrocycles and analogs thereof
US7378508B2 (en) 2007-01-22 2008-05-27 Optimer Pharmaceuticals, Inc. Polymorphic crystalline forms of tiacumicin B
CN102503994A (zh) 2005-10-21 2012-06-20 奥普蒂姆药物公司 治疗艰难梭菌相关的腹泻的方法
US20080176927A1 (en) 2007-01-19 2008-07-24 Optimer Pharmaceuticals, Inc. Compositions of stable tiacumicins
ZA200905337B (en) 2007-01-22 2010-10-27 Optimer Pharmaceuticals Inc Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
TWI523654B (zh) 2007-11-27 2016-03-01 默沙東藥廠 抗生素巨環化合物以及其製造及使用之方法

Also Published As

Publication number Publication date
JP5764168B2 (ja) 2015-08-12
TW200840562A (en) 2008-10-16
ES2821384T3 (es) 2021-04-26
US20100081800A1 (en) 2010-04-01
NZ578697A (en) 2012-08-31
EP3412678B1 (en) 2020-08-19
HRP20180912T1 (hr) 2018-07-27
RU2478643C2 (ru) 2013-04-10
EP2468761A1 (en) 2012-06-27
CA2676061A1 (en) 2008-07-31
WO2008091554A1 (en) 2008-07-31
PT2125850T (pt) 2018-07-11
TWI453015B (zh) 2014-09-21
CA2676061C (en) 2016-01-19
PL3412678T3 (pl) 2020-12-14
CY1120358T1 (el) 2019-07-10
NZ601347A (en) 2013-11-29
US20080194497A1 (en) 2008-08-14
US8859510B2 (en) 2014-10-14
JP2013241440A (ja) 2013-12-05
US7863249B2 (en) 2011-01-04
PL2125850T3 (pl) 2018-08-31
TR201810589T4 (tr) 2018-08-27
TW201350114A (zh) 2013-12-16
DK2125850T3 (en) 2018-07-30
IL199984A0 (en) 2010-04-15
ES2676308T3 (es) 2018-07-18
EP3412678A1 (en) 2018-12-12
MX348083B (es) 2017-05-25
KR20150006082A (ko) 2015-01-15
JP2010516681A (ja) 2010-05-20
HUE052444T2 (hu) 2021-05-28
US8883986B2 (en) 2014-11-11
CA2880860A1 (en) 2008-07-31
US20090163428A1 (en) 2009-06-25
EP2125850B1 (en) 2018-05-30
EP2125850A1 (en) 2009-12-02
TWI425942B (zh) 2014-02-11
JP5468388B2 (ja) 2014-04-09
US20070259949A1 (en) 2007-11-08
HUE039395T2 (hu) 2018-12-28
CN101663312A (zh) 2010-03-03
MX2009007730A (es) 2009-08-07
RU2009131727A (ru) 2011-02-27
PT3412678T (pt) 2020-09-29
CN102746353A (zh) 2012-10-24
AU2008209580A1 (en) 2008-07-31
CN101663312B (zh) 2013-10-23
BRPI0806878A2 (pt) 2014-06-24
US20130252914A1 (en) 2013-09-26
US7378508B2 (en) 2008-05-27
SI2125850T1 (en) 2018-08-31
IL220255A0 (en) 2012-07-31
KR20090117924A (ko) 2009-11-16

Similar Documents

Publication Publication Date Title
PT3412678T (pt) Polimorfos macrocíclicos, composições que compreendem tais polimorfos, e métodos de utilização e fabrico dos mesmos
HRP20190408T1 (hr) Ariloazol-2-il-cijanoetilamino-spojevi, postupak njihove proizvodnje i postupak njihove uporabe
HUS1900009I1 (hu) Új vegyületek és készítmények, továbbá alkalmazási eljárásaik
ZA200806842B (en) Imidazole-based compounds,compositions comprising them and methods of their use
ZA201308527B (en) Forms of rifaximin and uses thereof
PL3135720T3 (pl) Kompozycja środka porotwórczego z wodorochlorofluoroolefinową
EP1976675A4 (en) COMPOSITION, PREPARATION OF POLYCARBOSILANES AND THEIR USES
ZA200905337B (en) Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
ZA200905671B (en) Heterocyclic compounds, compositions comprising them and methods of their use
ZA201000992B (en) Anti-viral compounds, compositions, and methods of use
EP2340297A4 (en) COMPOSITION, ITS MANUFACTURING METHOD AND USE
IL205967A0 (en) Antibiotic macrocycle compounds and methods of manufacture and use thereof